Immatics NV (IMTX)

8.56 +0.19 (+2.27%) USD  |  NASDAQ  |  Sep 28, 15:54
More

Immatics Cash from Operations (Annual) : -199.34M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for IMTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2018. Start Trial.
Date Value
December 31, 2025 -199.34M
December 31, 2024 -170.94M
December 31, 2023 19.71M
December 31, 2022 105.24M
Date Value
December 31, 2021 -96.67M
December 31, 2020 -97.59M
December 31, 2019 76.16M
December 31, 2018 8.946M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
MediGene AG --
InflaRx NV -39.86M
BioNTech SE 514.63M
Twist Bioscience Corp. -47.63M
Prime Medicine, Inc. -162.56M